InVitroLogics ApS: Financial statements 2020
CVR: 34044562
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -41,211 and a net result of DKK -41,386 compared with DKK -5,252 the year before. Equity in the 2020 report amounted to DKK -356,061.
- Gross Profit
- DKK -41,211
- Profit/Loss
- DKK -41,386
- Equity
- DKK -356,061
- Total Assets
- DKK 80,177
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -41 t. | -41 t. | -356 t. | - |
| 2019 | - | -5 t. | -5 t. | -315 t. | - |
| 2018 | - | -5 t. | -16 t. | -309 t. | - |
| 2017 | - | -5 t. | -157 t. | -294 t. | - |
| 2016 | 4 t. | -205 t. | -222 t. | -137 t. | - |
Official annual report
How creditworthy is InVitroLogics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
InVitroLogics ApS has published its annual report for 2019. Gross profit came to DKK -5,238, and the net result was DKK -5,252.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.